COVID-19 and RAAS inhibitors: the controversy continues

Simple item page
dc.contributor.authorGovindapala, D.S.
dc.contributor.authorMatthias, A.T.
dc.contributor.authorManilgama, S.
dc.contributor.authorWanigatunge, C.A.
dc.date.accessioned2020-12-27T15:03:29Z
dc.date.available2020-12-27T15:03:29Z
dc.date.issued2020
dc.identifier.citationJournal of the Ceylon College of Physicians, 51(1):p.43-47
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/25200
dc.publisherCeylon College of Physicians:Rajagiriya
dc.subjectRAAS inhibitors
dc.subjectACEIs
dc.subjectARB
dc.subjectACE2
dc.subjectCOVID-19
dc.titleCOVID-19 and RAAS inhibitors: the controversy continues
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
JCCP_51_1_43.pdf
Size:
132.57 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Plain Text
Description:
Download

Collections

Journal of the Ceylon College of Physicians